{"blog": [], "keywords": [{"value": "Medical Marijuana", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Marijuana", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Drug Abuse and Traffic", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "United States Politics and Government", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Drug Enforcement Administration", "name": "organizations", "rank": "5", "is_major": "Y"}, {"value": "Research", "name": "subject", "rank": "6", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "7", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/08/12/health/dea-keeps-marijuana-on-list-of-dangerous-drugs-frustrating-advocates.html", "document_type": "article", "byline": {"person": [{"middlename": "Saint", "firstname": "Catherine", "role": "reported", "rank": 1, "lastname": "LOUIS", "organization": ""}], "original": "By CATHERINE SAINT LOUIS"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-thumbWide.jpg", "legacy": {"wide": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-articleLarge.jpg", "legacy": {"xlarge": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-articleLarge.jpg", "xlargeheight": "400", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 400}, {"url": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Health", "word_count": "910", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "The agency decided not to reclassify marijuana from a Schedule 1 drug to a Schedule 2 drug, but removed a roadblock to medical studies of marijuana.", "pub_date": "2016-08-12T04:00:00+0000", "news_desk": "National", "headline": {"print_headline": "D.E.A. Refusal to Reclassify Marijuana Draws Criticism", "main": "D.E.A. Keeps Marijuana on List of Dangerous Drugs, Frustrating Advocates"}, "print_page": "13", "snippet": "The agency decided not to reclassify marijuana from a Schedule 1 drug to a Schedule 2 drug, but removed a roadblock to medical studies of marijuana....", "_id": "57ad251b95d0e021d79803dd", "slideshow_credits": null, "abstract": "Drug Enforcement Agency refuses to reclassify marijuana from Schedule 1 drug to Schedule 2 drug, move that would remove it from list of nation's most dangerous drugs and ease research and medical use; decision angers scientists, public officials and advocates, although DEA says it will allow universities and private companies to apply to grow marijuana for research."}